Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Glycine
Drug ID BADD_D01033
Description A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
Indications and Usage Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
Marketing Status Prescription; Discontinued
ATC Code B05CX03
DrugBank ID DB00145
KEGG ID D00011
MeSH ID D005998
PubChem ID 750
TTD Drug ID D0M8AB
NDC Product Code 51927-1287; 49452-0400; 0338-0289; 16947-8205; 61960-5810; 12785-0005; 51552-0492; 0264-2302; 0264-7390; 48595-001; 17333-015; 12497-1010; 0990-7974
Synonyms Glycine | Aminoacetic Acid | Acid, Aminoacetic | Glycine, Copper Salt | Copper Salt Glycine | Glycine, Monosodium Salt | Monosodium Salt Glycine | Salt Glycine, Monosodium | Glycine, Sodium Hydrogen Carbonate | Glycine Carbonate (1:1), Monosodium Salt | Glycine Carbonate (2:1), Monolithium Salt | Glycine Carbonate (2:1), Monopotassium Salt | Glycine Carbonate (2:1), Monosodium Salt | Glycine Hydrochloride | Hydrochloride, Glycine | Glycine Hydrochloride (2:1) | Glycine Phosphate | Phosphate, Glycine | Glycine Phosphate (1:1) | Glycine Sulfate (3:1) | Glycine, Calcium Salt | Calcium Salt Glycine | Glycine, Calcium Salt (2:1) | Glycine, Cobalt Salt | Cobalt Salt Glycine | Glycine, Monopotassium Salt | Monopotassium Salt Glycine | Salt Glycine, Monopotassium | Glycine, Monoammonium Salt | Monoammonium Salt Glycine | Salt Glycine, Monoammonium
Chemical Information
Molecular Formula C2H5NO2
CAS Registry Number 56-40-6
SMILES C(C(=O)O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Thrombophlebitis24.01.02.001--Not Available
Urinary retention20.02.02.011--
Urticaria23.04.02.001; 10.01.06.001--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.06.008--Not Available
Vomiting07.01.07.003--
Respiratory tract congestion22.02.07.003--Not Available
Urinary tract obstruction20.08.01.004--
Toxicity to various agents12.03.01.046--Not Available
The 2th Page    First    Pre   2    Total 2 Pages